2023 Update to CMS’ Covered Indications for Sacroiliac Joint Injection

023 Update to the Sacroiliac Joint CMS Covered Indications for SI Joint Injection Long Island Based Interventional Pain Physician, David Rosenblum, MD discusses Sacroiliac Joint Dysfunction, and CMS’s Covered Indications for Sacroiliac Joint Injection and Diagnostic Nerve Block The CE experience for this Podcast is powered by CMEfy - click here to reflect and earn credits: https://earnc.me/ryGmAg For Board Review, Click Here! Sacroiliac Joint Injections are considered necessary and reasonable when all of the following criteria are met: Moderate to severe low back pain primarily experienced over the anatomical location of the SI joints between the upper level of the iliac crests and the gluteal fold, AND Low back pain duration of at least three (3) months, AND Low back pain below L5 without radiculopathy, AND Clinical findings and/or imaging studies do not suggest any other diagnosed or obvious cause of the lumbosacral pain (such as central spinal stenosis with neurogenic claudication/myelopathy, foraminal stenosis or disc herniation with concordant radicular pain/radiculopathy, infection, tumor, fracture, pseudoarthrosis, or pain related to spinal instrumentation), AND At least three positive findings with provocative maneuvers: FABER, Gaenslen, Thigh Thrust or Posterior Shear, SI Compression, SI Distraction and Yeoman Tests,3,4 AND Low back pain persists despite a minimum of four weeks of conservative therapies.5